Delray Beach, Fla. – September 15, 2026 -- The global biological safety cabinet market is projected to grow from USD 0.26 billion in 2026 to USD 0.36 billion by 2031, a 6.6% CAGR, according to MarketsandMarkets.
Pharma investment and biosafety upgrades drive containment equipment demand
Expansion of drug discovery, biologics, cell and gene therapy, and vaccine development is pushing laboratories to replace aging cabinets with certified, higher-performance containment systems. Rising biosafety requirements for handling infectious agents and hazardous materials are accelerating both new installations and equipment upgrades across clinical, academic, and pharmaceutical labs.
Class II cabinets dominate the market on broad laboratory applicability
Class II cabinets held the largest market share in 2025, favored across pharmaceutical, biopharmaceutical, clinical, academic, and microbiology settings for their combined personnel, product, and environmental protection. Configurations spanning Type A1, A2, B1, B2, and C1 let labs match airflow and exhaust needs, with Type A2 units widely deployed for routine microbiological and cell culture work. Class III cabinets, meanwhile, are set to post the highest CAGR through 2031.
Pharma and biopharma end users to post fastest growth through 2031
Pharma & biopharma organizations accounted for 44.4% of end-user market share in 2025 and are projected to register the highest CAGR from 2026 to 2031, driven by expanding biologics, vaccine, and cell and gene therapy manufacturing that requires strict contamination control and cabinet certification compliance.
North America commands 39% market share on strong biotech infrastructure
North America is expected to hold the largest regional share, 39.0%, in 2025, with the US as the primary demand driver given its dense concentration of biotechnology firms, clinical and academic research facilities, and leading cabinet manufacturers.
Kewaunee's $55 million NuAire acquisition reshapes competitive landscape
In November 2024, Kewaunee Scientific Corporation acquired NuAire for approximately USD 55 million, adding biological safety cabinets, airflow products, and pharmacy compounding isolators to its portfolio while expanding distribution reach. Labconco Corporation introduced a redesigned Logic Biosafety Cabinet in 2024 featuring a touchscreen interface, remote data access, automated airflow control, and up to 30% lower energy consumption.
The top five players -- Thermo Fisher Scientific, Kewaunee Scientific Corporation, Labconco Corporation, The Baker Company, and Esco Lifesciences -- are estimated to hold a significant share of total 2025 market revenue, pointing to a moderately consolidated competitive landscape built on certification capabilities and established laboratory relationships.